Publication
Interaction between cannabinoid type 1 and type 2 receptors in the modulation of subventricular zone and dentate Gyrus neurogenesis
| dc.contributor.author | Rodrigues, Rui S. | |
| dc.contributor.author | Ribeiro, Filipa | |
| dc.contributor.author | Ferreira, Filipa | |
| dc.contributor.author | Vaz, Sandra H. | |
| dc.contributor.author | Sebastião, Ana M | |
| dc.contributor.author | Xapelli, Sara | |
| dc.date.accessioned | 2021-07-26T14:55:59Z | |
| dc.date.available | 2021-07-26T14:55:59Z | |
| dc.date.issued | 2017 | |
| dc.description | Copyright © 2017 Rodrigues, Ribeiro, Ferreira, Vaz, Sebastião and Xapelli. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. | pt_PT |
| dc.description.abstract | Neurogenesis in the adult mammalian brain occurs mainly in two neurogenic niches, the subventricular zone (SVZ) and the subgranular zone (SGZ) of the dentate gyrus (DG). Cannabinoid type 1 and 2 receptors (CB1R and CB2R) have been shown to differently modulate neurogenesis. However, low attention has been given to the interaction between CB1R and CB2R in modulating postnatal neurogenesis (proliferation, neuronal differentiation and maturation). We focused on a putative crosstalk between CB1R and CB2R to modulate neurogenesis and cultured SVZ and DG stem/progenitor cells from early postnatal (P1-3) Sprague-Dawley rats. Data showed that the non-selective cannabinoid receptor agonist WIN55,212-2 promotes DG cell proliferation (measured by BrdU staining), an effect blocked by either CB1R or CB2R selective antagonists. Experiments with selective agonists showed that facilitation of DG cell proliferation requires co-activation of both CB1R and CB2R. Cell proliferation in the SVZ was not affected by the non-selective receptor agonist, but it was enhanced by CB1R selective activation. However, either CB1R or CB2R selective antagonists abolished the effect of the CB1R agonist in SVZ cell proliferation. Neuronal differentiation (measured by immunocytochemistry against neuronal markers of different stages and calcium imaging) was facilitated by WIN55,212-2 at both SVZ and DG. This effect was mimicked by either CB1R or CB2R selective agonists and blocked by either CB1R or CB2R selective antagonists, cross-antagonism being evident. In summary, our findings indicate a tight interaction between CB1R and CB2R to modulate neurogenesis in the two major neurogenic niches, thus contributing to further unraveling the mechanisms behind the action of endocannabinoids in the brain. | pt_PT |
| dc.description.sponsorship | This work was supported by LISBOA-01-0145-FEDER-007391, project co-funded by FEDER through POR Lisboa 2020 (Programa Operacional Regional de Lisboa) from PORTUGAL 2020, and by Fundação para a Ciência e a Tecnologia (FCT). AS thanks the following supports: PTDC/DTP-FTO/3346/2014 from FCT and H2020 Twinning Action from EU (SynaNet 692340). SX is grateful for the support by the COST action BM1402. RR (IMM/BI/42-2016), FR (SFRH/BD/74662/2010), SV (SFRH/BPD/81627/2011), and SX (SFRH/BPD/76642/2011 and IF/01227/2015) were in receipt of a fellowship from FCT. | pt_PT |
| dc.description.version | info:eu-repo/semantics/publishedVersion | pt_PT |
| dc.identifier.citation | Front Pharmacol. 2017 Aug 10;8:516. | pt_PT |
| dc.identifier.doi | 10.3389/fphar.2017.00516 | pt_PT |
| dc.identifier.eissn | 1663-9812 | |
| dc.identifier.uri | http://hdl.handle.net/10451/49125 | |
| dc.language.iso | eng | pt_PT |
| dc.peerreviewed | yes | pt_PT |
| dc.publisher | Frontiers | pt_PT |
| dc.relation | LISBOA-01-0145-FEDER-007391 | pt_PT |
| dc.relation | Synaptic mechanisms involved in the brain cannabinoid actions and their modulation by adenosine receptors: implications for memory and mood control | |
| dc.relation | Neurologic and Psychiatric Disorders: from synapses to networks | |
| dc.relation | ADENOSINE A2A RECEPTOR MODULATION OF NEURONAL MATURATION | |
| dc.relation | MODULATION OF THE BIDIRECTIONAL COMMUNICATION BETWEEN NEURONS AND ASTROCYTES AT THE SYNAPSE: INFLUENCE OF BDNF AND P2 RECEPTORS | |
| dc.relation | ENDOCANNABINOIDS AS MODULATORS OF NEUROGENESIS AND OLIGODENDROGENESIS: ROLE OF HEMOGLOBIN-DERIVED PEPTIDES | |
| dc.relation.publisherversion | https://www.frontiersin.org/journals/pharmacology | pt_PT |
| dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | pt_PT |
| dc.subject | Cannabinoid type 1 receptor | pt_PT |
| dc.subject | Cannabinoid type 2 receptor | pt_PT |
| dc.subject | Dentate gyrus | pt_PT |
| dc.subject | Postnatal neurogenesis | pt_PT |
| dc.subject | Subventricular zone | pt_PT |
| dc.title | Interaction between cannabinoid type 1 and type 2 receptors in the modulation of subventricular zone and dentate Gyrus neurogenesis | pt_PT |
| dc.type | journal article | |
| dspace.entity.type | Publication | |
| oaire.awardTitle | Synaptic mechanisms involved in the brain cannabinoid actions and their modulation by adenosine receptors: implications for memory and mood control | |
| oaire.awardTitle | Neurologic and Psychiatric Disorders: from synapses to networks | |
| oaire.awardTitle | ADENOSINE A2A RECEPTOR MODULATION OF NEURONAL MATURATION | |
| oaire.awardTitle | MODULATION OF THE BIDIRECTIONAL COMMUNICATION BETWEEN NEURONS AND ASTROCYTES AT THE SYNAPSE: INFLUENCE OF BDNF AND P2 RECEPTORS | |
| oaire.awardTitle | ENDOCANNABINOIDS AS MODULATORS OF NEUROGENESIS AND OLIGODENDROGENESIS: ROLE OF HEMOGLOBIN-DERIVED PEPTIDES | |
| oaire.awardURI | info:eu-repo/grantAgreement/FCT/3599-PPCDT/PTDC%2FDTP-FTO%2F3346%2F2014/PT | |
| oaire.awardURI | info:eu-repo/grantAgreement/EC/H2020/692340/EU | |
| oaire.awardURI | info:eu-repo/grantAgreement/FCT//SFRH%2FBD%2F74662%2F2010/PT | |
| oaire.awardURI | info:eu-repo/grantAgreement/FCT//SFRH%2FBPD%2F81627%2F2011/PT | |
| oaire.awardURI | info:eu-repo/grantAgreement/FCT/OE/SFRH%2FBPD%2F76642%2F2011/PT | |
| oaire.awardURI | info:eu-repo/grantAgreement/FCT/Investigador FCT/IF%2F01227%2F2015%2FCP1317%2FCT0001/PT | |
| oaire.citation.title | Frontiers in Pharmacology | pt_PT |
| oaire.citation.volume | 8 | pt_PT |
| oaire.fundingStream | 3599-PPCDT | |
| oaire.fundingStream | H2020 | |
| oaire.fundingStream | OE | |
| oaire.fundingStream | Investigador FCT | |
| person.familyName | Rodrigues | |
| person.familyName | Ribeiro | |
| person.familyName | Henriques Vaz | |
| person.familyName | Sebastião | |
| person.familyName | Xapelli | |
| person.givenName | Rui S | |
| person.givenName | Filipa | |
| person.givenName | Sandra Cristina | |
| person.givenName | Ana M | |
| person.givenName | Sara | |
| person.identifier | 129383 | |
| person.identifier.ciencia-id | 6916-485D-36C3 | |
| person.identifier.ciencia-id | 0E1C-952D-61BE | |
| person.identifier.ciencia-id | F112-55E8-E37E | |
| person.identifier.ciencia-id | 7110-C8C3-ED42 | |
| person.identifier.orcid | 0000-0002-9343-745X | |
| person.identifier.orcid | 0000-0002-4006-7328 | |
| person.identifier.orcid | 0000-0003-4258-9397 | |
| person.identifier.orcid | 0000-0001-9030-6115 | |
| person.identifier.orcid | 0000-0001-6854-2509 | |
| person.identifier.rid | S-1079-2018 | |
| person.identifier.scopus-author-id | 7004409879 | |
| person.identifier.scopus-author-id | 8721560200 | |
| project.funder.identifier | http://doi.org/10.13039/501100001871 | |
| project.funder.identifier | http://doi.org/10.13039/501100008530 | |
| project.funder.identifier | http://doi.org/10.13039/501100001871 | |
| project.funder.identifier | http://doi.org/10.13039/501100001871 | |
| project.funder.identifier | http://doi.org/10.13039/501100001871 | |
| project.funder.identifier | http://doi.org/10.13039/501100001871 | |
| project.funder.name | Fundação para a Ciência e a Tecnologia | |
| project.funder.name | European Commission | |
| project.funder.name | Fundação para a Ciência e a Tecnologia | |
| project.funder.name | Fundação para a Ciência e a Tecnologia | |
| project.funder.name | Fundação para a Ciência e a Tecnologia | |
| project.funder.name | Fundação para a Ciência e a Tecnologia | |
| rcaap.rights | openAccess | pt_PT |
| rcaap.type | article | pt_PT |
| relation.isAuthorOfPublication | 80c7b611-e2d2-4481-9468-0bcb1bc8095c | |
| relation.isAuthorOfPublication | 45abc672-83ac-42b0-97d5-06f5633530f8 | |
| relation.isAuthorOfPublication | b282e0fa-69eb-4079-8752-b7dd914f7745 | |
| relation.isAuthorOfPublication | 304abd7f-071b-4447-a8a3-4aa5f0547141 | |
| relation.isAuthorOfPublication | b4bd1deb-458d-4981-bd54-46ddf93a1927 | |
| relation.isAuthorOfPublication.latestForDiscovery | 80c7b611-e2d2-4481-9468-0bcb1bc8095c | |
| relation.isProjectOfPublication | ef224f38-d3c7-4f75-95c0-2515f847a1e0 | |
| relation.isProjectOfPublication | a8d0a09b-e946-45d0-ac79-0b6e4fff9e49 | |
| relation.isProjectOfPublication | 9dadf8dd-d035-43b9-b5eb-7962e47a8379 | |
| relation.isProjectOfPublication | 6de556d4-f49f-470e-a41e-957bed5e0b79 | |
| relation.isProjectOfPublication | 8a18b2e7-3b02-4152-9ddf-21791826205d | |
| relation.isProjectOfPublication | f7800cfa-e1ce-4954-95dd-fec35d82a5a0 | |
| relation.isProjectOfPublication.latestForDiscovery | ef224f38-d3c7-4f75-95c0-2515f847a1e0 |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Interaction_Cannabinoid.pdf
- Size:
- 1.64 MB
- Format:
- Adobe Portable Document Format
